Cardiovascular complications in COVID-19: A systematic review and meta-analysis - 25/07/20
Doi : 10.1016/j.jinf.2020.05.068
Setor K. Kunutsor a, b, ⁎ 
, Jari A. Laukkanen c, d, e
, Jari A. Laukkanen c, d, e a National Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, UK
b Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Learning & Research Building (Level 1), Southmead Hospital, Bristol, UK
c Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland
d Institute of Clinical Medicine, Department of Medicine, University of Eastern Finland, Kuopio, Finland
e Central Finland Health Care District Hospital District, Department of Medicine, Jyväskylä, Finland District, Jyväskylä, Finland
⁎Corresponding author. Translational Health Sciences, Bristol Medical School, University of Bristol, Learning & Research Building (Level 1), Southmead Hospital, Bristol, BS10 5NB, UK; Phone: +44-7539589186; Fax: +44-1174147924.Translational Health SciencesBristol Medical School, University of Bristol, Learning & Research Building (Level 1), Southmead HospitalBristolBS10 5NBUK
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
© 2020
Elsevier Ltd. Tous droits réservés.
Vol 81 - N° 2
P. e139-e141 - août 2020 Retour au numéro
Article précédent
- Interleukin-17: A potential therapeutic target in COVID-19
- Vicky M. Montaño Mendoza
- A Pneumonia Screening System based on Parasympathetic Activity Monitoring in Non-contact Way using Compact Radars Beneath the Bed Mattress.
- Takemi Matsui, Tsuyoshi Kobayashi, Masaya Hirano, Masahiro Kanda, Guanghao Sun, Yusuke Otake, Masakazu Okada, Sadao Watanabe, Yuikiya Hakozaki
Bienvenue sur EM-consulte, la référence des professionnels de santé.